Pfizer's Acquisition of Hospira in 2015 Pfizer concluded its deal with Hospira in September 2015 for about $17 billion
BPC-157 may support the bodys repair signaling for soft tissue, tendon, ligament, and muscle concerns
The uneducated clinicians will say, you dont have Intrinsic factor antibodies (IFA) so you dont have pernicious anaemia (PA) and so you will stay on tablets because we decided you can now miraculously absorb B12 from food! This ludicrous concept crops up frequently (I have blogged about it before here.) It needs repeating so often PA is just one of many causes and they are all serious and need correct treatment
Additionally, BPC 157 is present in most tissues (Seiwerth et al., 2018), where it can bind reactive free radicals and inactivate them at crucial positions not reachable by other antioxidants (Sikiric et al., 1993
The gap is in large-scale human randomised controlled trials, which have not yet been conducted